The NAMPT enzyme employs a switch that directly senses AMP/ATP and regulates cellular responses to energy stress.

Mol Cell

Institute for Translational Medicine on Cell Fate and Disease, Shanghai Ninth People's Hospital, Key Laboratory of Cell Differentiation and Apoptosis of National Ministry of Education, Department of Pathophysiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; School of

Published: June 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Nicotinamide adenine dinucleotide (NAD) is a crucial compound in energy metabolism and cell signaling. Nicotinamide phosphoribosyltransferase (NAMPT) is the rate-limiting enzyme responsible for NAD biosynthesis from nicotinamide (NAM). Here, we report that NAMPT activity is inhibited by adenosine monophosphate (AMP) in response to energy stress. Our global metabolite-protein interaction mapping reveals that NAMPT differentially interacts with AMP from fasted mouse livers. Crystal structures of NAMPT-AMP show that AMP binds similarly to the NAMPT reaction product, nicotinamide mononucleotide (NMN). The inhibition of NAMPT by AMP can be relieved by NAMPT activators or adenosine triphosphate (ATP), likely in a competitive manner. Based on these findings, we further investigated upstream factors contributing to AMP accumulation and found that activation of purine synthesis unexpectedly promotes the rise of AMP during fasting. Notably, an increased AMP/ATP ratio correlates with NAD decline in ischemic stroke models, in which NAMPT activators can otherwise confer protection.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molcel.2025.05.022DOI Listing

Publication Analysis

Top Keywords

nampt
8
energy stress
8
nampt activators
8
amp
6
nampt enzyme
4
enzyme employs
4
employs switch
4
switch directly
4
directly senses
4
senses amp/atp
4

Similar Publications

NAMPT Is A Novel Inhibitor of Vascular Calcification in Chronic Kidney Disease.

Arterioscler Thromb Vasc Biol

September 2025

Department of Cardiology, Laboratory of Heart Center, Heart Center, Zhujiang Hospital, Southern Medical University, China. (Q.D., X.Z., L.F., A.C., Z.L., Y.Y., J.Z., X.L., Y.L., J.Y.).

Background: Vascular calcification is very common in patients with chronic kidney disease and contributes to the increased risk of cardiovascular events. NAMPT (nicotinamide phosphoribosyltransferase), the rate-limiting enzyme in the salvage pathway of nicotinamide adenine dinucleotide, has been shown to exert an antiaging effect on vascular smooth muscle cells. However, whether NAMPT is involved in the regulation of vascular calcification remains unclear.

View Article and Find Full Text PDF

Multi-omics reveals mechanism of Qi-Po-Sheng-Mai granule in reducing atrial fibrillation susceptibility in aged rats.

Chin Med

September 2025

Department of Cardiovascular, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, 5 Beixiange Street, Xicheng District, Beijing, 100053, People's Republic of China.

Background: Atrial Fibrillation (AF) is the most common arrhythmia in clinical practice, and age is an independent risk factor for the development of AF. Qi-Po-Sheng-Mai granule (QPSM) has been used clinically to treat aging-related AF, however, its underlying mechanisms remain incompletely understood.

Methods: In this study, we established a D-galactose-induced aging rat model to evaluate the effects of QPSM on aging-related AF through electrocardiograms, echocardiography, and histopathological analysis.

View Article and Find Full Text PDF

Nicotinamide adenine dinucleotide (NAD) is a critical metabolic co-enzyme implicated in brain aging, and augmenting NAD levels in the aging brain is an attractive therapeutic strategy for neurodegeneration. However, the molecular mechanisms of brain NAD regulation are incompletely understood. In cardiac tissue, the circadian nuclear receptor REV-ERBα has been shown to regulate NAD via control of the NAD-producing enzyme NAMPT.

View Article and Find Full Text PDF

Integrating large-scale in vitro functional genomic screen and multi-omics data to identify novel breast cancer targets.

Breast Cancer Res Treat

September 2025

Yale School of Medicine, Yale Cancer Center, 300 George Street, Suite 120, Rm 133, New Haven, CT, 06511, USA.

Purpose: Our goal is to leverage publicly available whole transcriptome and genome-wide CRISPR-Cas9 screen data to identify and prioritize novel breast cancer therapeutic targets.

Methods: We used DepMap dependency scores > 0.5 to identify genes that are potential therapeutic targets in 48 breast cancer cell lines.

View Article and Find Full Text PDF

Interferon-gamma (IFN-γ) is a key regulator of immune responses. A hallmark of IFN-γ responses is inducible nitric oxide (NO), driven primarily by nitric oxide synthase (NOS)2. In this study, we investigated the influence of NO on the IFN-γ-induced transcriptomic and metabolic changes in the RAW 264.

View Article and Find Full Text PDF